LIFE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 3.70%

Insider Buying (Last 12 Months): $136,160.00

Insider Selling (Last 12 Months): $0.00

aTyr Pharma Insider Trading History Chart

aTyr Pharma Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 06/4/2024 10:09 PM ET

I’m giving you the name of this investment for free

From Porter & Company | Ad

This key unlocks a new pathway to wealth that has been kept hidden from you for decades. In my new documentary I will provide you with all the details of this one-of-a-kind investment.

Let me explain in this new documentary video

aTyr Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/31/2024	Jill Marie Broadfoot	CFO	Buy	5,000	$1.79	$8,950.00	27,960
5/31/2024	Sanjay Shukla	CEO	Buy	20,000	$1.81	$36,200.00	136,548
5/30/2024	Timothy Coughlin	Director	Buy	50,000	$1.75	$87,500.00	56,000
12/11/2023	Sanjay Shukla	CEO	Buy	3,000	$1.17	$3,510.00	94,173
5/10/2023	Paul Schimmel	Director	Buy	200,000	$2.25	$450,000.00	313,023
2/6/2023	Jill Marie Broadfoot	CFO	Sell	1,566	$2.36	$3,695.76	15,460
11/21/2022	Sanjay Shukla	CEO	Buy	10,000	$2.14	$21,400.00	50,798
7/1/2022	Sanjay Shukla	CEO	Buy	15,000	$2.88	$43,200.00	40,798
1/13/2022	Jill Marie Broadfoot	CFO	Buy	1,923	$6.75	$12,980.25
11/15/2021	Sanjay Shukla	CEO	Buy	2,500	$8.57	$21,425.00
9/20/2021	Paul Schimmel	Director	Buy	250,000	$8.00	$2,000,000.00

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”

From Paradigm Press | Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

SEC Filings (Institutional Ownership Changes) for aTyr Pharma (NASDAQ:LIFE)

61.72% of aTyr Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

aTyr Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/10/2024	Acadian Asset Management LLC	45,366	$87K	0.0%	+119.6%	0.066%
5/10/2024	Vanguard Group Inc.	2,652,157	$5.17M	0.0%	+12.0%	3.843%
5/7/2024	SG Americas Securities LLC	28,256	$55K	0.0%	N/A	0.041%
5/3/2024	GSA Capital Partners LLP	224,147	$0.44M	0.0%	+105.3%	0.330%
4/15/2024	Kingswood Wealth Advisors LLC	60,000	$0.12M	0.0%	N/A	0.088%
2/14/2024	Pale Fire Capital SE	293,706	$0.41M	0.1%	+425.8%	0.502%
2/13/2024	Stonepine Capital Management LLC	482,258	$0.68M	0.3%	-89.6%	0.824%
1/29/2024	Granite Bay Wealth Management LLC	18,000	$25K	0.0%	N/A	0.031%
11/14/2023	Pale Fire Capital SE	55,857	$88K	0.0%	N/A	0.095%
11/13/2023	Federated Hermes Inc.	10,169,600	$16.07M	0.0%	-0.2%	17.366%
11/13/2023	FMR LLC	8,556,925	$13.52M	0.0%	+5.1%	14.612%
8/11/2023	D.A. Davidson & CO.	22,750	$49K	0.0%	+89.6%	0.042%
7/24/2023	Vontobel Holding Ltd.	30,000	$65K	0.0%	N/A	0.055%
5/15/2023	Stonepine Capital Management LLC	4,825,722	$10.13M	3.4%	N/A	8.888%
5/8/2023	Federated Hermes Inc.	10,189,966	$21.40M	0.1%	+94.8%	19.168%
2/15/2023	Tang Capital Management LLC	123,430	$0.27M	0.0%	-88.9%	0.425%
2/14/2023	VR Adviser LLC	1,171,436	$2.57M	0.4%	-89.1%	4.038%
2/9/2023	Citigroup Inc.	428,460	$0.94M	0.0%	N/A	1.497%
11/17/2022	Telemetry Investments L.L.C.	492,500	$1.48M	1.9%	+10.2%	1.720%
11/14/2022	VR Adviser LLC	10,698,889	$36.74M	5.4%	+664.8%	37.376%
7/28/2022	D.A. Davidson & CO.	10,800	$31K	0.0%	N/A	0.038%
5/16/2022	Tikvah Management LLC	1,350,833	$7.23M	2.3%	+10.2%	4.860%
5/16/2022	Deep Track Capital LP	1,028,515	$5.50M	0.4%	-6.5%	3.700%
2/15/2022	Stonepine Capital Management LLC	525,531	$3.93M	1.8%	+28.0%	1.891%
2/14/2022	Deep Track Capital LP	1,100,000	$8.22M	0.6%	N/A	3.958%
2/14/2022	GSA Capital Partners LLP	58,791	$0.44M	0.1%	N/A	0.212%
2/14/2022	Tikvah Management LLC	1,225,833	$9.16M	2.6%	N/A	4.411%
2/10/2022	Qube Research & Technologies Ltd	11,665	$87K	0.0%	N/A	0.042%
2/9/2022	Dimensional Fund Advisors LP	226,712	$1.69M	0.0%	+1.1%	0.816%
2/8/2022	Raymond James & Associates	24,584	$0.18M	0.0%	N/A	0.088%
2/1/2022	Qube Research & Technologies Ltd	11,665	$87K	0.0%	N/A	0.042%
11/16/2021	Tang Capital Management LLC	1,113,453	$10.11M	2.1%	N/A	6.581%
11/16/2021	Two Sigma Advisers LP	482,450	$4.38M	0.0%	+302.2%	2.851%
11/16/2021	Two Sigma Investments LP	541,721	$4.92M	0.0%	+3,650.0%	3.202%
11/16/2021	Telemetry Investments L.L.C.	165,318	$1.50M	2.0%	-7.8%	0.977%
11/16/2021	VR Adviser LLC	1,565,000	$14.21M	1.8%	N/A	9.249%
11/15/2021	Cubist Systematic Strategies LLC	51,327	$0.47M	0.0%	N/A	0.303%
11/15/2021	Marshall Wace LLP	43,006	$0.39M	0.0%	N/A	0.254%
11/15/2021	Tocqueville Asset Management L.P.	14,850	$0.14M	0.0%	N/A	0.088%
11/15/2021	Dimensional Fund Advisors LP	224,279	$2.04M	0.0%	+1.5%	1.326%
11/12/2021	Renaissance Technologies LLC	179,655	$1.63M	0.0%	+1.9%	1.062%
11/12/2021	Stonepine Capital Management LLC	410,535	$3.73M	1.7%	N/A	2.426%
11/12/2021	Geode Capital Management LLC	130,282	$1.18M	0.0%	+18.7%	0.770%
11/12/2021	EAM Global Investors LLC	152,792	$1.39M	0.3%	N/A	0.903%
11/12/2021	EAM Investors LLC	259,791	$2.36M	0.4%	N/A	1.535%
11/9/2021	BlackRock Inc.	217,012	$1.97M	0.0%	-3.5%	1.283%
11/3/2021	Sheaff Brock Investment Advisors LLC	11,000	$100K	0.0%	N/A	0.065%
8/16/2021	Alyeska Investment Group L.P.	1,274,747	$6.22M	0.1%	+29.6%	7.817%
8/16/2021	Telemetry Investments L.L.C.	179,308	$0.88M	1.2%	+51.7%	1.100%
8/16/2021	State Street Corp	55,199	$0.27M	0.0%	N/A	0.338%
8/13/2021	Renaissance Technologies LLC	176,255	$0.86M	0.0%	-27.2%	1.097%
8/13/2021	Northern Trust Corp	26,105	$0.13M	0.0%	+18.5%	0.162%
8/13/2021	Geode Capital Management LLC	109,761	$0.54M	0.0%	+82.2%	0.683%
8/13/2021	Vanguard Group Inc.	595,202	$2.90M	0.0%	+101.7%	3.705%
8/13/2021	FMR LLC	1,675,880	$8.18M	0.0%	+5.8%	10.432%
8/12/2021	XTX Topco Ltd	12,265	$60K	0.0%	N/A	0.076%
8/12/2021	Dimensional Fund Advisors LP	220,928	$1.08M	0.0%	+243.1%	1.375%
8/11/2021	Susquehanna International Group LLP	10,839	$53K	0.0%	N/A	0.067%
5/21/2021	Citadel Advisors LLC	13,470	$60K	0.0%	N/A	0.084%
5/18/2021	Alyeska Investment Group L.P.	983,594	$4.38M	0.1%	+16.7%	6.143%
5/18/2021	Citadel Advisors LLC	13,470	$60K	0.0%	N/A	0.084%
5/17/2021	Ikarian Capital LLC	300,000	$1.34M	0.0%	-25.0%	1.874%
5/14/2021	Dimensional Fund Advisors LP	64,400	$0.29M	0.0%	+236.6%	0.402%
5/13/2021	Renaissance Technologies LLC	241,960	$1.08M	0.0%	-24.2%	1.511%
5/12/2021	Geode Capital Management LLC	60,248	$0.27M	0.0%	+24.0%	0.376%
5/11/2021	Acadian Asset Management LLC	102,697	$0.46M	0.0%	+23.7%	0.641%
5/7/2021	BlackRock Inc.	253,389	$1.13M	0.0%	+528.3%	1.583%
2/24/2021	Virtu Financial LLC	27,736	$0.11M	0.0%	N/A	0.272%
2/24/2021	Alyeska Investment Group L.P.	842,554	$3.27M	0.0%	+11.9%	8.272%
2/16/2021	Alyeska Investment Group L.P.	842,554	$3.27M	0.0%	+11.9%	8.272%
2/12/2021	Ikarian Capital LLC	400,000	$1.55M	0.1%	N/A	3.927%
2/10/2021	Renaissance Technologies LLC	319,130	$1.24M	0.0%	-21.9%	3.133%
11/13/2020	Ardsley Advisory Partners LP	20,000	$65K	0.0%	N/A	0.200%
11/9/2020	Acadian Asset Management LLC	83,052	$0.27M	0.0%	+22.2%	0.830%
11/6/2020	BlackRock Inc.	41,411	$0.13M	0.0%	+23.8%	0.414%
9/15/2020	Two Sigma Advisers LP	80,950	$0.36M	0.0%	+122.7%	0.849%
8/14/2020	Alyeska Investment Group L.P.	725,984	$3.22M	0.1%	-1.7%	7.763%

Data available starting January 2016

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

Today's Range

Now: N/A

50 Day Range

MA: $1.76

$1.57

$2.07

52 Week Range

Now: N/A

Volume

269,400 shs

Average Volume

514,103 shs

Market Capitalization

$131.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Who are the company insiders with the largest holdings of aTyr Pharma?: aTyr Pharma's top insider investors include:
Paul Schimmel (Director)
Sanjay Shukla (CEO)
Timothy Coughlin (Director)
Jill Marie Broadfoot (CFO)
Learn More about top insider investors at aTyr Pharma.